Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,404 | 434 | 98.9% |
| Education | $99.99 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,034 | 116 | $0 (2024) |
| GENZYME CORPORATION | $1,240 | 37 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $821.17 | 30 | $0 (2024) |
| Merz North America, Inc. | $593.01 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $497.10 | 22 | $0 (2024) |
| Lilly USA, LLC | $401.46 | 21 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $389.93 | 19 | $0 (2024) |
| Incyte Corporation | $382.05 | 17 | $0 (2024) |
| Galderma Laboratories, L.P. | $334.27 | 21 | $0 (2024) |
| LEO Pharma Inc. | $332.09 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,028 | 93 | ABBVIE INC. ($506.70) |
| 2023 | $2,750 | 115 | Merz North America, Inc. ($593.01) |
| 2022 | $1,753 | 77 | ABBVIE INC. ($403.16) |
| 2021 | $1,107 | 56 | AbbVie Inc. ($347.60) |
| 2020 | $133.68 | 8 | GENZYME CORPORATION ($35.38) |
| 2019 | $711.65 | 36 | Regeneron Healthcare Solutions, Inc. ($193.65) |
| 2018 | $780.69 | 42 | GENZYME CORPORATION ($233.36) |
| 2017 | $239.49 | 8 | Allergan Inc. ($170.16) |
All Payment Transactions
435 individual payment records from CMS Open Payments — Page 3 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ACNE | ||||||
| 05/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $43.20 | General |
| Category: Immunology | ||||||
| 05/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $49.32 | General |
| Category: Immunology | ||||||
| 05/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.78 | General |
| Category: Immunology | ||||||
| 04/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.29 | General |
| Category: Dermatology | ||||||
| 04/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Dermatology | ||||||
| 04/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Dermatology | ||||||
| 04/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2024 | Almirall LLC | Seysara (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Dermatology | ||||||
| 03/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: DERMATOLOGY | ||||||
| 03/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Dermatology | ||||||
| 03/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.90 | General |
| Category: Dermatology | ||||||
| 03/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: IMMUNOLOGY | ||||||
| 03/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.96 | General |
| Category: Immunology | ||||||
| 03/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/06/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Podiatry | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Dermatology | ||||||
| 02/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,608 | 2,552 | $384,793 | $107,129 |
| 2022 | 14 | 891 | 1,583 | $230,049 | $71,685 |
| 2021 | 11 | 671 | 1,223 | $158,223 | $51,735 |
| 2020 | 13 | 603 | 838 | $83,619 | $33,017 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 344 | 423 | $82,485 | $27,093 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 261 | $67,338 | $20,039 | 29.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 276 | 364 | $62,244 | $13,856 | 22.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 179 | 204 | $47,940 | $13,638 | 28.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 72 | 86 | $24,940 | $6,864 | 27.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 183 | 826 | $14,042 | $4,155 | 29.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 98 | 102 | $14,586 | $3,972 | 27.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 16 | $12,448 | $3,838 | 30.8% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 49 | 55 | $14,520 | $3,241 | 22.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 50 | 70 | $9,170 | $2,765 | 30.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 17 | 20 | $6,300 | $1,737 | 27.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $8,773 | $1,731 | 19.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 12 | $4,380 | $1,538 | 35.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $8,125 | $1,267 | 15.6% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 14 | $3,552 | $769.80 | 21.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 20 | $2,900 | $599.17 | 20.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 35 | $1,050 | $26.96 | 2.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 218 | 292 | $67,382 | $25,915 | 38.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 171 | 242 | $44,631 | $9,293 | 20.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 98 | 127 | $27,448 | $8,695 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 75 | $12,582 | $4,975 | 39.5% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2022 | 35 | 49 | $11,448 | $3,068 | 26.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 31 | 37 | $9,690 | $3,051 | 31.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 106 | 538 | $13,799 | $2,898 | 21.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 13 | 20 | $8,399 | $2,656 | 31.6% |
About Dr. Corinne Erickson, MD
Dr. Corinne Erickson, MD is a Specialist healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1134321037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Corinne Erickson, MD has received a total of $9,504 in payments from pharmaceutical and medical device companies, with $2,028 received in 2024. These payments were reported across 435 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($9,404).
As a Medicare-enrolled provider, Erickson has provided services to 3,773 Medicare beneficiaries, totaling 6,196 services with total Medicare billing of $263,566. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Dermatology, Procedural Dermatology
- Location Atlanta, GA
- Active Since 06/03/2007
- Last Updated 06/24/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134321037
Products in Payments
- DUPIXENT (Biological) $1,300
- SKYRIZI (Biological) $874.28
- RINVOQ (Biological) $510.85
- OPZELURA (Drug) $382.05
- TREMFYA (Drug) $379.14
- TALTZ (Drug) $376.17
- EUCRISA (Drug) $326.34
- DUPIXENT (Drug) $286.91
- Sotyktu (Drug) $282.28
- HUMIRA (Biological) $269.73
- ADBRY (Biological) $228.11
- Humira (Biological) $227.64
- Otezla (Drug) $194.04
- Winlevi (Drug) $177.07
- AKLIEF (Drug) $135.24
- COSENTYX (Drug) $122.96
- REMICADE (Biological) $117.96
- COSENTYX (Biological) $116.04
- ENSTILAR (Drug) $103.98
- DUPIXENT DUPILUMAB INJECTION (Biological) $103.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Atlanta
Melhem Solh, M.d, M.D
Specialist — Payments: $1.1M
Sumayah Taliaferro, Md, MD
Specialist — Payments: $98,474
Theresa Jarmuz, M.d, M.D
Specialist — Payments: $98,072
Dr. Scott Solomon, M.d, M.D
Specialist — Payments: $59,894
Dr. Asad Bashey, M.d, M.D
Specialist — Payments: $45,487
Dr. Bronier Costas, M.d, M.D
Specialist — Payments: $45,325